Skip to main content
SpringerLink
Log in

Resistant Hypertension in Patients with Chronic Kidney Disease

  • Chapter
  • First Online:
Chronic Kidney Disease and Hypertension

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

  • 2637 Accesses

Abstract

Chronic kidney disease (CKD) is a major public health problem around the world. Despite our understanding of the pathophysiology of CKD, its prevalence is steadily escalating to hazardous proportions due to the increasing incidence of hypertension, diabetes, metabolic syndrome, and other risk factors. Hypertension can be a cause or consequence of CKD. Nevertheless, the coexistence of hypertension and CKD portends poor prognosis due to the occurrence of premature and extensive cardiovascular disease. It is therefore a matter of urgency and a challenge to control hypertension effectively in patients with CKD. Aggressive therapeutic strategies should be applied to prevent the onset and progression of hypertension in patients with CKD. Ultimately, it is the blood pressure level which determines the prognosis of patients afflicted with CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kidney Disease Outcomes Quality Initiative Work Group. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(Suppl 1):S1–290.

    Google Scholar 

  2. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. American heart association professional education committee: resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American heart association professional education committee of the council for high blood pressure research. Circulation. 2008;117:510–26.

    Article  Google Scholar 

  3. The National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206–52.

    Article  Google Scholar 

  4. El Nahas AM, Bello AK. Chronic kidney disease. The global challenge. Lancet. 2005;365:331–40.

    Article  Google Scholar 

  5. De Nicola L, Minutolo R, Castellino P, et al. Target blood pressure levels in chronic kidney disease (TABLE in CKD) study group. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69:538–45.

    Article  CAS  PubMed  Google Scholar 

  6. Minutolo R, De Nicola L, Zamboli P, Chiodini P, Signoriello G, Toderico C, et al. Management of hypertension in patients with CKD. Differences between primary and tertiary care settings. Am J Kidney Dis. 2005;46:18–25.

    Article  PubMed  Google Scholar 

  7. Schwenger V, Ritz E. Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant. 1998;13:3091–5.

    Article  CAS  PubMed  Google Scholar 

  8. Dasgupta RJ, Madeley RJ, Pringle MAL, Savill J, Burden RP. Management of hypertension in patients developing end-stage renal failure. Q J Med. 1999;92:519–25.

    Article  CAS  Google Scholar 

  9. Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Levey AS, Milas NC, et al. Achievement and safety of a low blood pressure goal in chronic renal disease. Hypertension. 1997;29:641–50.

    Article  CAS  PubMed  Google Scholar 

  10. Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, et al. Impact of achieved blood pressure on cardiovascular outcomes in the irbesartan diabetic nephropathy trial. J Am Soc Nephrol. 2005;16:2170–9.

    Article  CAS  PubMed  Google Scholar 

  11. Cianciaruso B, Bellizzi V, Minutolo R, et al. Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol. 1996;7(2):306–13.

    CAS  PubMed  Google Scholar 

  12. Konishi Y, Okada N, Okamura M, et al. Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin A nephropathy. Hypertension. 2001;38(1):81–5.

    Article  CAS  PubMed  Google Scholar 

  13. Bigazzi R, Kogosov E, Campese VM. Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol. 1994;4:1901–7.

    CAS  PubMed  Google Scholar 

  14. Kohan DE. Endothelin, hypertension, and chronic kidney disease: new insights. Curr Opin Nephrol Hypertens. 2010;19:134–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Neuhofer W, Pittrow D. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence. Eur J Clin Invest. 2009;39(Suppl 2):50–67.

    Article  CAS  PubMed  Google Scholar 

  16. Longaretti L, Benigni A. Endothelin receptor selectivity in chronic renal failure. Eur J Clin Invest. 2009;39(Suppl 2):32–7.

    Article  CAS  PubMed  Google Scholar 

  17. Zanatta CM, Gerchman F, Burttet L, et al. Endothelin-1 levels and albuminuria inpatients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2008;80:299–304.

    Article  CAS  PubMed  Google Scholar 

  18. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D’Agostino RB, Newman AB, Lebowitz MD, Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep heart health study. JAMA. 2000;283:1829–36.

    Article  CAS  PubMed  Google Scholar 

  19. Peker Y, Kraiczi H, Hedner J, Loth S, Johansson A, Bende M. An independent association between obstructive sleep apnea and coronary artery disease. Eur Respir J. 1999;14:179–84.

    Article  CAS  PubMed  Google Scholar 

  20. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, O’Connor GT, Boland LL, Schwartz JE, Samet JM. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. Am J Respir Crit Care Med. 2001;163:19–25.

    Article  CAS  PubMed  Google Scholar 

  21. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–41.

    Article  CAS  PubMed  Google Scholar 

  22. Unruh ML, Sanders MH, Redline S, Piraino BM, Umans JG, Hammond TC, Sharief I, Punjabi NM, Newman AB. Sleep apnea in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the sleep heart health study. J Am Soc Nephrol. 2006;17:3503–9.

    Article  PubMed  Google Scholar 

  23. Sim JJ, Rasgon SA, Kujubu DA, Kumar VA, Liu IL, Shi JM, Pham TT, Derose SF. Sleep apnea in early and advanced chronic kidney disease: Kaiser permanente Southern California cohort. Chest. 2009;135:710–16.

    Article  PubMed  Google Scholar 

  24. Agrawal V, Vanhecke TE, Rai B, Franklin BA, Sangal RB, McCullough PA. Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea. Nephron Clin Pract. 2009;113:c140–7.

    Article  PubMed  Google Scholar 

  25. Rosas SE. Sleep apnea in individuals with chronic kidney disease: a wake-up call. Clin J Am Soc Nephrol. 2011;6:954–956.

    Article  PubMed  Google Scholar 

  26. Zoccali C, Benedetto FA, Tripepi G, et al. Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int. 1998;53:1078–84.

    Article  CAS  PubMed  Google Scholar 

  27. Farmer CK, Goldsmith DJ, Cox J, et al. An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant. 1997;12:2301–7.

    Article  CAS  PubMed  Google Scholar 

  28. Peixoto AJ, White WB. Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance. Curr Opin Nephrol Hypertens. 2002;11:507–16.

    Article  PubMed  Google Scholar 

  29. Amar J, Vernier I, Rossignol E, et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int. 2000;57:2485–91.

    Article  CAS  PubMed  Google Scholar 

  30. Cachofeiro V, Goicochea M, de Vinuesa SG, et al. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2008;74 (Suppl 111):S4–9.

    Article  Google Scholar 

  31. Nicola LD, Gabbai FB, Agarwal R, et al. Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients. J Am Coll Cardiol. 2013;61:2461–7.

    Article  PubMed  Google Scholar 

  32. Weinrauch LA, Desai AS, Skali H, et al. Risk stratification of resistant hypertension in chronic kidney disease. J Am Coll Cardiol. 2013;61:2468–70.

    Article  PubMed  Google Scholar 

  33. Salles GF, Cardoso CR, Pereira VS, Fiszman R, Muxfeldt ES. Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study. J Hypertens. 2011;29:2014–23.

    Article  CAS  PubMed  Google Scholar 

  34. Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension. Atherosclerosis. 2011;216:199–204.

    Article  CAS  PubMed  Google Scholar 

  35. De Nicola L, Borrelli S, Gabbai FB, et al. Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease. Kidney Blood Press Res. 2011;34:58–67.

    Article  PubMed  Google Scholar 

  36. Agarwal R, Andersen MJ. Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension. 2005;46:514–20.

    Article  CAS  PubMed  Google Scholar 

  37. Rose BD. Diuretics. Kidney Int. 1991;39:336–52.

    Article  CAS  PubMed  Google Scholar 

  38. Vaclavik J, Sedlak R, Plachy M, et al. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial. Hypertension. 2011;57:1069–75.

    Article  CAS  PubMed  Google Scholar 

  39. Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease; the role of blood pressure, proteinuria, and angiotensin converting enzyme inhibition. A patient-level meta-analysis. Ann Intern Med. 2003;139:244–52.

    Article  CAS  PubMed  Google Scholar 

  40. Hatta T, Takeda K, Shiotsuy Y, et al. Switching to an L/N-type calcium channel blocker shows renoprotective effects in patients with chronic kidney disease: the Kyoto cilnidipine study. J Int Med Res. 2012;40:1417–28.

    Article  CAS  PubMed  Google Scholar 

  41. Hering D, Mahfoud F, Walton AS, Krum H, et al. Renal denervation in moderate to severe CKD. J Am Soc Nephrol. 2012;23:1250–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Rifkin DE, Sarnak MJ. How low can you go? Blood pressure and mortality in chronic kidney disease. Ann Intern Med. 2013;159:302–3.

    Article  PubMed  Google Scholar 

  43. Ram CVS, Silverstein RL. “Refractory” resistant hypertension: new terminology for an old problem. J Clin Hyperten. 2012;14:5–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. President’s Estate Clinic, Rashtrapati Bhawan, Bungalow No. 5, Mother Teresa Cresent, New Delhi, Delhi, India

    Mohsin Wali

  2. Department of Cardiology, Apollo Hospitals, Hyderabad, Andhra Pradesh, India

    Sudhir R. Naik

  3. Texas Blood Pressure Institute, Apollo Hospitals, Hyderabad, India

    C. Venkata S. Ram

  4. Texas Blood Pressure Institute, Apollo Hospitals, Dallas, TX, USA

    C. Venkata S. Ram

Authors
  1. Mohsin Wali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sudhir R. Naik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Venkata S. Ram
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohsin Wali .

Editor information

Editors and Affiliations

  1. Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland, USA

    Matthew R. Weir

  2. Section of Nephrology, University of Illinois at Chicago/Advocate Christ Medical Center, Oak Lawn, Illinois, USA

    Edgar V. Lerma

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wali, M., Naik, S., Ram, C. (2015). Resistant Hypertension in Patients with Chronic Kidney Disease. In: Weir, M., Lerma, E. (eds) Chronic Kidney Disease and Hypertension. Clinical Hypertension and Vascular Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1982-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1982-6_3

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1981-9

  • Online ISBN: 978-1-4939-1982-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation